Affiliate disclosure
We earn a commission if you sign up with Shed through the links on this page. It did not buy a favourable review. This is an updated version of our earlier review, and the rating has come down slightly on the strength of the complaint record described below.
Shed is a US telehealth provider selling compounded GLP-1 medication in an unusually wide range of formats — weekly injections, but also sublingual drops and lozenges for people who will not use needles — alongside a separate pathway to brand-name products. Founded in December 2022 and operating in all 50 states, it claims more than 150,000 members. It is aimed at people who want GLP-1 treatment without injections, and on that specific need it has fewer competitors than almost any provider we cover. It also has a complaint history that includes a formal BBB warning, which it appears to have worked through.
Overview
Shed is a licensed telehealth platform founded in December 2022, operating nationwide. It combines compounded GLP-1 medication with a care team, optional premium coaching, and a results guarantee. The company states it has served more than 150,000 members; we could not verify that figure independently and report it as a company claim.
What genuinely distinguishes it is the format range. Most providers offer a weekly injection and nothing else; a handful add an oral tablet. Shed offers sublingual drops and lozenges as well. For patients with a real needle aversion — which is common enough to keep people off treatment entirely — that is a meaningful option.
Shed and ShedRx Are the Same Company
You will see this business under two names, and the split matters when you research it. Shed and ShedRx refer to the same provider, and complaints, reviews and BBB records are distributed across both.
That means any single rating you find is likely to be measuring only part of the picture — a 4.5 Trustpilot score under one name sits alongside a much heavier complaint record under the other. We flag this because dual branding is itself something to weigh: it makes a company harder to research, whether or not that is the intention. We also carry a separate ShedRx review on this site, which we are consolidating with this one.
Shed at a Glance
| Medications offered | Compounded semaglutide and tirzepatide as injections, sublingual drops or lozenges; brand-name GLP-1s via a separate subscription pathway |
|---|---|
| Brand-name or compounded | Compounded products are not FDA-approved. The brand-name pathway supplies FDA-approved medication at pharmacy prices |
| Consultation process | Online intake with licensed provider review |
| Eligibility | Assessed at intake; criteria not published in detail |
| Provider involvement | Care team support included; premium coaching available as a paid add-on |
| Lab requirements | Not stated as required |
| Pharmacy fulfillment | Not named |
| Shipping frequency | Included; complaints describe charges without medication arriving |
| Support services | Text-based support, with reported delays of around 24 hours; no live phone line reported |
| Membership fees | None on the compounded plans; the brand-name pathway is a $99/month subscription |
| Medication fees | Compounded semaglutide from about $199/month and tirzepatide from about $299; premium coaching $49.99/month extra |
| Cancellation policy | Subscription-based; cancellation terms not published in detail |
| Refund policy | A 10% weight-loss money-back guarantee is offered, subject to its own conditions |
| Insurance | Not accepted on the compounded plans |
| HSA/FSA | Stated as HSA/FSA eligible |
| Availability | All 50 states |
Pricing and the Add-Ons
| Option | Reported price | Status |
|---|---|---|
| Compounded semaglutide | From ~$199/mo | Not FDA-approved |
| Compounded tirzepatide | From ~$299/mo | Not FDA-approved |
| Brand-name pathway | $99/mo subscription + pharmacy price | FDA-approved medication |
| Premium coaching | +$49.99/mo | Optional add-on |
At around $199, Shed's compounded semaglutide is mid-to-upper market — double Cora Health and Trimi at $99, and level with TrimRx. You are paying for format choice and the care team rather than for the cheapest medication.
Two structural points worth noting. The brand-name pathway is a genuinely useful option — a $99/month subscription with medication at pharmacy prices means you can access FDA-approved product through the same provider, which most compounded sellers cannot offer. And the $49.99 coaching add-on is exactly that: an add-on. Do not assume behavioural support is included in the headline price, because it is not.
Drops and Lozenges: The Evidence Question
Sublingual drops and lozenges are Shed's signature offering, and they deserve an honest assessment rather than a sales pitch.
Semaglutide is a peptide, and peptides are poorly absorbed through the mouth and gut without help. The FDA-approved oral semaglutide product achieves absorption using a specific absorption enhancer developed and tested for that purpose. A compounded sublingual drop or lozenge is not that product and has not been through the same testing. Published pharmacokinetic work puts oral semaglutide bioavailability at roughly 0.02% to 0.9% of a subcutaneous dose, against about 89% for the injection — the same problem we set out in our Wisp review.
That does not mean these formats do nothing. It does mean there is no published evidence establishing what proportion of the dose reaches your bloodstream, or how consistent that is between doses and between patients. If you choose a needle-free compounded format, you are accepting more uncertainty about the dose you actually receive than an injection carries. For someone who would otherwise not treat at all, that trade may be worth making — but make it knowingly, and discuss it with the prescribing clinician.
The FDA-approved alternative for needle-avoidance is the Wegovy pill, sold by NovoCare Pharmacy at $149/month and by Ro from $149 plus membership. If avoiding injections is your reason for choosing Shed, price those first — they are cheaper and approved.
The BBB Warning, and What Happened Next
The Better Business Bureau issued a pattern-of-complaints warning against ShedRx. The company responded with a plan to address the issues raised, and the profile now carries an A rating.
We want to give that its proper weight in both directions. A pattern-of-complaints designation is not issued lightly — it means the BBB judged the problems systematic rather than isolated. But engaging with the process and remediating to an A is the outcome the system is designed to produce, and it is more than several companies in this category have managed. WellMedr sits at an F with an open alert; MEDVi at an F. Shed had the same kind of problem and fixed the record.
What tempers the credit is that complaints of the same type have not entirely stopped. Reports across BBB and consumer review sites continue to describe customers being charged without receiving medication, and difficulty reaching live support — contact is text-based, with delays commonly around 24 hours and no phone line reported. A remediation plan that improves a rating without eliminating the underlying complaint is progress rather than resolution.
The 10% Weight-Loss Guarantee
Shed offers a money-back guarantee tied to achieving 10% weight loss. Guarantees of this shape are common in the category and almost always carry conditions — typically requiring documented adherence, a minimum treatment duration, and sometimes weigh-ins or check-ins at specified points.
We could not obtain the full conditions, and we would not sign up on the strength of the headline alone. Ask specifically: how long you must stay on treatment to qualify, what adherence documentation is required, whether missed check-ins void it, and whether the refund covers medication or only fees. We have seen these guarantees in this market that, read closely, exclude everyone in a position to claim — WellMedr's is a clear example. Shed's may well be better; get it in writing and find out.
Eligibility, Contraindications, and Side Effects
Shed operates in all 50 states and assesses eligibility at intake. See our eligibility guide for what a proper screen covers.
Semaglutide and tirzepatide carry a boxed warning regarding thyroid C-cell tumours, based on rodent studies. You should not take these medications if you or a family member have had medullary thyroid carcinoma, if you have Multiple Endocrine Neoplasia syndrome type 2, or if you have had a serious hypersensitivity reaction to the active ingredient. They are not for use in pregnancy. A history of pancreatitis, gallbladder disease, gastroparesis or other severe gastrointestinal disease, or diabetic retinopathy, warrants specific discussion first.
Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and abdominal pain — worst after a dose increase. Serious but less common risks include pancreatitis, gallbladder disease and acute kidney injury from dehydration. Choosing drops or lozenges does not avoid these; the drug is the same, and uncertain absorption cuts both ways — an unexpectedly high absorbed dose is as possible as a low one. Our side effects guide covers management.
We are not quoting weight-loss figures for Shed. It publishes no outcome data for its own patients, and brand-name trial results do not transfer to compounded products — least of all to sublingual formats whose absorption is unestablished.
How Shed Compares
| Provider | Semaglutide from | Needle-free option | FDA-approved? | Our rating |
|---|---|---|---|---|
| Shed | ~$199 | Drops and lozenges | No — compounded | 3.7 / 5 |
| TrimRx | $179 oral | Oral tablet | No — compounded | 3.4 / 5 |
| NovoCare Pharmacy | $149 | Wegovy pill | Yes | 4.5 / 5 |
| Ro | $149 + membership | Wegovy pill, Foundayo | Yes | 3.7 / 5 |
Shed has the widest format range, but two of its competitors offer needle-free options that are FDA-approved and cheaper. Shed's drops and lozenges are unique; that uniqueness is partly because no approved product works that way.
Pros and Cons
Pros
- The widest range of delivery formats we have catalogued
- Sublingual drops and lozenges for genuine needle aversion
- A brand-name pathway giving access to FDA-approved medication
- Around 4.5 / 5 across roughly 500 Trustpilot reviews
- Operates in all 50 states
- 10% weight-loss money-back guarantee offered
- Stated as HSA/FSA eligible
- Care team included, with optional premium coaching
- Engaged with the BBB complaint process and remediated to an A rating
- Trading since December 2022 with a substantial claimed member base
Cons
- Previously subject to a BBB pattern-of-complaints warning
- Continuing reports of being charged without receiving medication
- Text-only support with delays around 24 hours and no phone line
- Sublingual absorption is not established — dose delivered is uncertain
- At ~$199 it is double the cheapest compounded providers
- Coaching is a $49.99/month add-on, not included
- Compounding pharmacy not named
- Dual Shed / ShedRx branding makes the record harder to research
- Guarantee conditions not published in full
- Cancellation terms not published in detail
Who Should Pick It, and Who Should Look Elsewhere
Shed suits you if needle aversion is genuinely stopping you from treating, you have considered the approved oral options and they do not work for you, and you want a provider that will also route you to brand-name medication if the compounded route stops making sense. The format range is real, the Trustpilot record is good, and the company has demonstrated it will engage with a regulator-adjacent complaint process rather than ignore it.
Look elsewhere if you simply want the cheapest compounded semaglutide — Cora Health and Trimi are half the price and name their pharmacies. Look elsewhere if you want a needle-free option with established absorption, where the FDA-approved Wegovy pill at $149 is both cheaper and better evidenced. And if being unable to reach a human quickly would worry you, note that support here is text-only.
Limitations of This Review
This review is based on independent coverage, BBB records and review platforms, checked on 7 August 2026. Pricing figures come from third-party reporting rather than a rate card we verified directly, and the dual Shed/ShedRx branding means review and complaint data are split across two names in ways we cannot fully reconcile. We could not obtain the full conditions of the 10% guarantee, the cancellation terms, or the identity of the compounding pharmacy, and we could not verify the claimed 150,000 members. We have not signed up, been prescribed, or received medication.
Frequently Asked Questions
How much does Shed cost?
Compounded semaglutide from around $199/month and tirzepatide from around $299. A brand-name pathway is available at a $99/month subscription plus pharmacy prices for the medication. Premium coaching is an extra $49.99/month.
Are Shed and ShedRx the same company?
Yes. The business trades under both names, which splits its reviews and complaint records across two identities and makes it harder to research. Bear that in mind when comparing ratings.
Do the sublingual drops actually work?
There is no published evidence establishing how much of the dose is absorbed from compounded sublingual drops or lozenges. Semaglutide is a peptide and is poorly absorbed without a purpose-built absorption enhancer, which the FDA-approved oral product uses and a compounded drop does not. Treat the dose you actually receive as uncertain.
What is Shed's BBB rating?
The profile carries an A rating. The BBB had previously issued a pattern-of-complaints warning against ShedRx; the company responded with a remediation plan and the rating improved. Complaints about charges without delivery have not entirely stopped.
How does the 10% weight-loss guarantee work?
Shed offers a money-back guarantee tied to achieving 10% weight loss, but the full conditions are not published. Ask how long you must remain on treatment, what adherence evidence is required, and whether the refund covers medication or only fees, before relying on it.
Is Shed's medication FDA-approved?
The compounded products — injections, drops and lozenges — are not FDA-approved. The separate brand-name pathway does supply FDA-approved medication, at pharmacy prices plus the subscription.
Verdict
3.7 / 5
The best answer in this market for genuine needle aversion, and a company that actually fixed its BBB record — held back by unestablished sublingual absorption, mid-upper pricing, and charges that customers say arrived without medication.
Shed does two things that matter. It offers formats nobody else does, which for a patient who will not inject is the difference between treatment and no treatment; and when the BBB found a pattern of complaints, it engaged and remediated to an A rather than letting the record stand. Both count. What holds the rating at 3.7 is that the flagship product's absorption is unestablished, the price is double the cheapest compounded options, and the specific complaint that matters most — paying and not receiving medication — is still being reported. If you need needle-free and the approved pill will not do, this is the place. Otherwise there are cheaper, better-evidenced routes.
Medical Disclaimer & Review Date
This review is general consumer information, not medical advice. GLP-1 medications are prescription drugs with serious contraindications, and whether any treatment is appropriate for you is a decision only a licensed healthcare provider who knows your medical history can make. Nothing here should be used to start, stop, or change a medication.
Details in this review come from Shed's own published materials as of the date below. Pricing, medication availability, state coverage, and policies in this category change frequently — verify current terms directly with the provider before purchasing.
Date reviewed: August 7, 2026
Price the Approved Pill First
If avoiding needles is the reason you are here, compare the FDA-approved Wegovy pill before committing to a compounded sublingual format — it is cheaper and its absorption is established.